Favorable Outcome of Preoperative Low Dose Chemoradiotherapy Against Muscle-Invasive Bladder Cancer
Authors:
- Minato YokoyamaMYMinato Yokoyama
- Yasuyuki SakaiYSYasuyuki Sakai
- Kazutaka SaitoKSKazutaka Saito
- Fumitaka KogaFumitaka Koga
- Masataka YanoMYMasataka Yano
- Gaku AraiGAGaku Arai
- Nobuhiko HyochiNHNobuhiko Hyochi
- Hitoshi MasudaHMHitoshi Masuda
- Yasuhisa FujiiYFYasuhisa Fujii
- Satoru KawakamiSKSatoru Kawakami
- Tsuyoshi KobayashiTKTsuyoshi Kobayashi
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 26 (5) , 504-507
Abstract
To investigate the feasibility of preoperative low-dose chemoradiotherapy, 50 patients with localized muscle-invasive bladder cancer (T2–T4) were treated with concurrent cisplatin (100 mg/body × 2 courses) and pelvic irradiation (40 Gy). Among 20 patients (40%) who achieved clinical complete regression, 11 with solitary tumor underwent partial cystectomy because of advanced age, poor condition of the patients, or a reluctance to have radical surgery. Radical cystectomy was carried out in the remaining 39 cases (complete regression 9, partial regression 30). Pathologic T0 response (no residual tumor) was achieved in 18 (36%) of all the cases. Median follow-up was 19 months (range 2–59 months). Estimated 3-year disease-free survival was 75% for all patients and 100% for T0 responders. Local recurrence (2 patients) or distant metastasis (6 patients) developed in 8 of 32 patients with pathologic persistent tumor. All of the 11 patients (9 with T0 response and 2 with a small residual tumor nest) who underwent partial cystectomy were recurrence free for observation periods up to 59 months. Low-dose chemoradiotherapy is as effective as other neoadjuvant protocols and is applicable to high-risk patients. The bladder can be preserved by partial cystectomy in selected cases with clinical complete regression.Keywords
This publication has 11 references indexed in Scilit:
- Preoperative Concurrent Chemoradiotherapy Against Muscle-invasive Bladder Cancer: Results of Partial Cystectomy in Elderly or High-risk PatientsJapanese Journal of Clinical Oncology, 2000
- AN UPDATE OF COMBINED MODALITY THERAPY FOR PATIENTS WITH MUSCLE INVADING BLADDER CANCER USING SELECTIVE BLADDER PRESERVATION OR CYSTECTOMYJournal of Urology, 1999
- Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.Journal of Clinical Oncology, 1998
- Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology, 1996
- Concurrent Cisplatin and Radiotherapy for Patients with Muscle Invasive Bladder Cancer Who are not Candidates for Radical CystectomyJournal of Urology, 1996
- Organ-sparing treatment of advanced bladder cancer: A 10-year experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladderCancer, 1985
- Concurrent Radiation and Cisplatin in the Treatment of Advanced Bladder Cancer: A Preliminary ReportJournal of Urology, 1982
- Reporting results of cancer treatmentCancer, 1981